Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: ciprofloxacin

« Back to Dashboard
Ciprofloxacin is the generic ingredient in fourteen branded drugs marketed by Bayer Hlthcare, Lupin Ltd, Bayer Pharms, Bedford Labs, Claris Lifesciences, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira, Teva Pharms Usa, Acs Dobfar Info Sa, Baxter Hlthcare, Bedford, Teva Pharms, Alcon Pharms Ltd, Akorn Inc, Apotex Inc, Fdc Ltd, Igi Labs Inc, Nexus Pharms, Pharmaforce, Watson Labs Inc, Wraser Pharms, Depomed Inc, Apotex, Aurobindo Pharma, Barr, Carlsbad, Dr Reddys Labs Ltd, Hikma, Ivax Sub Teva Pharms, Mylan, Nostrum Labs, Pliva, Ranbaxy, Sandoz, Taro, Teva, Unique Pharm Labs, Watson Labs, Actavis Labs Fl Inc, Anchen Pharms, and Mylan Pharms Inc, and is included in fifty-nine NDAs. There are twelve patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are thirty drug master file entries for ciprofloxacin. One supplier is listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: ciprofloxacin

Tradenames:14
Patents:12
Applicants:42
NDAs:59
Drug Master File Entries: see list30
Suppliers: see list1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for Ingredient: ciprofloxacin

Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial

Tentative approvals for CIPROFLOXACIN

Applicant Application No. Form Dosage
<disabled><disabled>TABLET; ORAL100MG
<disabled><disabled>Tablet; Oral100MG

Clinical Trials for: ciprofloxacin

Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis
Status: Completed Condition: Cystic Fibrosis

Impact of Formulation on Ciprofloxacin Oral Absorption
Status: Completed Condition: Healthy

Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin
Status: Completed Condition: Healthy

Ciprofloxacin for Prevention of BK Infection
Status: Recruiting Condition: BK Virus Infection

Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis
Status: Completed Condition: Otitis Externa; Otorhinolaryngologic Diseases; Ear Diseases; Otitis

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis
Status: Completed Condition: Bronchiectasis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
You have an error in your SQL syntax; check the manual that corresponds to your MySQL server version for the right syntax to use near 'LIMIT 5' at line 4